|
The investigation determined that lower than expected vitros ipth results have occurred with two different correlation samples when comparing results obtained from serum and plasma samples collected from the same patients.The samples were tested on the same vitros 5600 integrated system.The assignable cause could not be determined with the information provided.The majority of the samples in the repeat test event were tested 1 - 2 hours after the initial test event.The storage conditions between test events were not provided.In both events, the samples that were tested later had lower than expected results, regardless of whether the samples were serum or plasma.The special precautions sections of the vitros ipth ifu states: "intact pth is labile and susceptible to fragmentation.Correct handling of patient samples is necessary to ensure that the pth molecule remains intact.The degree of fragmentation will depend on both time and temperature of storage." it is possible that fragmentation of the ipth in the samples prior to being tested with the later test event caused those vitros ipth results to be lower than the vitros ipth results obtained from the initial test event.However, this could not be confirmed.Quality control results obtained within the timeframe of the event were acceptable, therefore, a performance issue with vitros ipth reagent lot 2110 did not likely contribute to the event.There is no indication of an instrument malfunction and unexpected instrument performance is not a likely contributor to the event.However, it cannot be completely ruled out as diagnostic within run precising testing was not performed at the time of the event.Continual tracking and trending of complaints has not identified any signals that would point to a potential systemic issue with vitros ipth lot 2110.
|